DIN 02565382 — KEYTRUDA SC 165 MG
KEYTRUDA SC is a solution of Pembrolizumab marketed by MERCK CANADA INC. The full Pembrolizumab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02565382
- Brand name
- KEYTRUDA SC
- Active ingredient
- Pembrolizumab
- Strength
- 165 MG
- Dosage form
- SOLUTION
- Route
- SUBCUTANEOUS
- Manufacturer
- MERCK CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Antineoplastic agent, PD-1 immune checkpoint inhibitor (monoclonal antibody)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Pembrolizumab products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02456869 | KEYTRUDA | 25 MG | SOLUTION | MERCK CANADA INC | MARKETED |